Humira (Hu-MARE-ah), a new biologic therapy for rheumatoid arthritis
February 2003
Abbott is now introducing Humira (Hu-MARE-ah), a new biologic therapy for rheumatoid arthritis.
It's a tumor necrosis factor blocking agent...similar to Remicade (infliximab) and Enbrel (etanercept).
Humira is adalimumab...a human-derived antibody that binds to tumor necrosis factor (TNF).
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote